Hearing Loss and Parkinson's Disease: Insights From Human and Animal Studies. [PDF]
Yu X +7 more
europepmc +1 more source
10d, a Pyridoquinoxaline-Based P-Glycoprotein Inhibitor, Exacerbates MPTP-Induced Neurotoxicity in PC12 Cells. [PDF]
Cannas C +4 more
europepmc +1 more source
Mitochondrial calcium and ROS: present understanding and future directions. [PDF]
Roth CI +6 more
europepmc +1 more source
Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson's disease. [PDF]
Chen W +6 more
europepmc +1 more source
Striatal temporal interference stimulation alleviates motor deficits and confers neuroprotection in an MPTP-induced mouse model of Parkinson's disease with associated improvements in mitochondrial homeostasis. [PDF]
Peng J, Wang Z, Liu Y, Wang X.
europepmc +1 more source
Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease. [PDF]
André MM +5 more
europepmc +1 more source
Preventive Attenuation of MPTP-Induced Parkinson's Disease-like Abnormalities by <i>Lactiplantibacillus plantarum</i> SHOU LAC-1 in Mice. [PDF]
Zhao W +13 more
europepmc +1 more source
NLRX1 emerges as the only observed essential regulator of the mPTP, challenging mPTP inhibition as a valid target of cardioprotection. [PDF]
Zuurbier KR, Zuurbier CJ.
europepmc +1 more source
NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson's Disease. [PDF]
Powell WH +4 more
europepmc +1 more source
Cross-species molecular stratification enables T cell receptor diagnosis of Parkinson's disease. [PDF]
Chen J +8 more
europepmc +1 more source

